ClinicalTrials.gov - Phase 3 Oncology Trials

Phase 3 Ovarian Cancer Trial, Decitabine Priming Added

ClinicalTrials.gov record for NCT02159820: a Phase 3 interventional study evaluating decitabine priming in ovarian cancer treatment. The trial is registered as an active study with an overall status of 'Recruiting'. No regulatory compliance deadlines, enforcement actions, or substantive rule changes are associated with this database entry.

NK105 vs Paclitaxel, Phase 3 Breast Cancer Trial

A Phase 3 clinical trial (NCT01644890) comparing NK105 versus paclitaxel for breast cancer treatment has been registered on ClinicalTrials.gov. The trial is listed under the National Institutes of Health registry with study ID NCT01644890.

Al18F-NOTA-FAPI PET/CT Imaging for Malignant Tumors (NCT05749302)

ClinicalTrials.gov registry entry NCT05749302 for a Phase 3 interventional study evaluating Al18F-NOTA-FAPI PET/CT imaging in participants with malignant tumors. The trial is registered on ClinicalTrials.gov, operated by the National Library of Medicine under NIH, and classified as Phase 3.